Aclaris Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ACRS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -8.94 M-13.06 M-9.99 M-10.93 M-13.13 M -47.11 M Cash from investing activities -88.72 M19.12 M5.05 M13.83 M10.37 M 48.37 M Cash from financing activities 74.58 M-275 K-9 000-3.04 M-2.53 M -5.86 M Free cash flow -8.94 M-13.93 M-10.01 M-10.96 M-13.15 M -48.06 M

뉴스

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

아클라리스 테라퓨틱스, H.C. Wainwright ’매수’ 등급 재확인

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

스티펠, Aclaris Therapeutics 목표 주가 3달러로 상향

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris Therapeutics Inc Q4 실적, 수익 에상치보다 저조

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris, 천식 환자 대상 ATI-052 1b상 임상시험 개시

Aclaris starts phase 1b trial of ATI-052 in asthma patients